Results 101 to 110 of about 395,238 (233)

Accelerating Global Measles and Rubella Eradication—Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic

open access: yesVaccines
No vaccine has been more effective in reducing disease burden, especially in preventing child deaths, than measles-containing vaccine. The return on investment makes measles-containing vaccine one of the most cost-effective public health measures ...
David N. Durrheim   +5 more
doaj   +1 more source

Genetic associations with mumps and rubella antibody response after MMR vaccination in 6- and 15-month-old children

open access: yesVaccine: X
Background: Measles, mumps, and rubella (MMR) vaccines have significantly improved public health worldwide. However, variation in vaccine response among immunized individuals poses a threat to both individual protection and herd immunity.
Jesper Kiehn Sørensen   +10 more
doaj   +1 more source

MMR vaccine (measles, mumps, rubella) : what you need to know [Vietnamese]

open access: yes
MMR vaccine (measles, mumps, rubella) : what you need to know [Vietnamese]MMR VIS \u2013 Vietnamese (8/6/21)vietnamese_mmr ...

core  

Measles, mumps, and rubella [PDF]

open access: yes
This online series of 15 webinars provides an overview of the principles of vaccination, general recommendations, immunization strategies for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent them.

core  

Measles, Mumps, Rubella, and Varicella Combination Vaccine: Safety and Immunogenicity Alone and in Combination with Other Vaccines Given to Children

open access: yes, 2020
Eight hundred and twelve children, 12 months to 3.5 years of age, were enrolled in two clinical studies to evaluate the safety and immunogenicity of a live, attenuated combination vaccine for measles, mumps, rubella, and varicella (MMRV).
Brenda Staehle   +8 more
core  

Rubella Vaccine Uptake among Women of Childbearing Age in Healthcare Settings. [PDF]

open access: yesHealthcare (Basel), 2023
Ferrari C   +8 more
europepmc   +1 more source

STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA

open access: yesПедиатрическая фармакология, 2010
Experts at FSUE R&D Centre Microgen of the RF’s Healthcare Ministry have developed a national drug designed to prevent rubella — Cultural live vaccine against rubella on the basis of vaccinal strain RA 27/3.
A.N. Mironov   +5 more
doaj   +2 more sources

MMR vaccine (measles, mumps, rubella) : what you need to know [Dari]

open access: yes
MMR vaccine (measles, mumps, rubella) : what you need to know [Dari]MMR VIS \u2013 Dari (8/6/21)dari_mmr ...

core  

MMR vaccine (measles, mumps, rubella) : what you need to know [Spanish]

open access: yes
MMR vaccine (measles, mumps, rubella) : what you need to know [Spanish]MMR VIS \u2013 Spanish (8/6/21)spanish_mmr ...

core  

Home - About - Disclaimer - Privacy